The table below shows Pharma Penny Stocks Under Rs 100 based on the Highest Market Capitalization.
| Name | Market Cap (₹ Cr) | Close Price (₹) |
| Morepen Laboratories Ltd | 4,566.65 | 83.34 |
| Syncom Formulations (India) Ltd | 1,719.26 | 20.49 |
| Nectar Lifesciences Ltd | 820.57 | 36.59 |
| Medico Remedies Ltd | 480.89 | 57.95 |
| Gennex Laboratories Ltd | 474.23 | 20.85 |
| Ambalal Sarabhai Enterprises Ltd | 449.61 | 58.67 |
| Shukra Pharmaceuticals Ltd | 289.35 | 66.08 |
| Remedium Lifecare Ltd | 270.95 | 6.72 |
| Pharmaids Pharmaceuticals Ltd | 266.52 | 75.57 |
| Vaishali Pharma Ltd | 237.7 | 18.22 |
Content:
- What Are Pharma Penny Stocks?
- Top 10 Pharma Penny Stocks Under Rs 100
- Pharma Penny Stocks Under Rs 100 In India
- Best Pharma Penny Stocks Under Rs 100
- List Of Best Pharma Penny Stocks Under Rs. 100
- Who Should Invest In Pharma Penny Stocks Under Rs 100?
- How To Invest In The Pharma Penny Stocks Under Rs 100?
- Performance Metrics Of Pharma Penny Stocks Under Rs 100
- Benefits Of Investing In Pharma Penny Stocks Under Rs 100
- Challenges Of Investing In Pharma Penny Stocks Under Rs 100
- Introduction To Pharma Penny Stocks Under Rs 100
- Top 10 Pharma Penny Stocks Under Rs 100- FAQs
What Are Pharma Penny Stocks?
Pharma penny stocks in the Indian stock market are shares of small pharmaceutical companies priced below Rs 10. These stocks are highly speculative and involve significant risk due to their low market capitalization and potential for high volatility.
Investing in these stocks can be enticing due to the potential for substantial returns if a company succeeds in breakthrough developments or regulatory approvals. However, the risk of losing the entire investment is also considerably higher compared to more stable stocks.
Investors interested in pharma penny stocks should perform extensive due diligence, focusing on the company’s drug pipeline, market potential, and financial health. Understanding regulatory environments and market dynamics within India is crucial for assessing these investments.
Top 10 Pharma Penny Stocks Under Rs 100
The table below shows the Top 10 Pharma Penny Stocks Under Rs 100 based on 1 Year Return.
| Name | Close Price (₹) | 1-Year Return (%) |
| Bacil Pharma Ltd | 49.04 | 549.54 |
| Gujarat Terce Laboratories Ltd | 82.31 | 243.24 |
| Shukra Pharmaceuticals Ltd | 66.08 | 164.8 |
| Morepen Laboratories Ltd | 83.34 | 131.18 |
| Desh Rakshak Aushdhalaya Ltd | 13.65 | 127.12 |
| Syncom Formulations (India) Ltd | 20.49 | 125.16 |
| Emmessar Biotech and Nutrition Ltd | 52.74 | 117.39 |
| Tiaan Consumer Ltd | 6.31 | 113.9 |
| Shamrock Industrial Company Ltd | 10.2 | 106.48 |
| Welcure Drugs and Pharmaceuticals Ltd | 7.69 | 99.22 |
Pharma Penny Stocks Under Rs 100 In India
The table below shows Pharma Penny Stocks Under Rs 100 In India based on 1 Month Return.
| Name | Close Price (₹) | 1-Month Return (%) |
| Pharmaids Pharmaceuticals Ltd | 75.57 | 75.56 |
| Bacil Pharma Ltd | 49.04 | 51.15 |
| Tiaan Consumer Ltd | 6.31 | 46.59 |
| Chemo Pharma Laboratories Ltd | 86 | 44.63 |
| Norris Medicines Ltd | 22.84 | 31.48 |
| Vilin Bio Med Ltd | 23.7 | 27.76 |
| Emmessar Biotech and Nutrition Ltd | 52.74 | 25.73 |
| Shelter Pharma Ltd | 54.14 | 23.91 |
| Colinz Laboratories Ltd | 63.27 | 23.19 |
| Panjon Ltd | 22.7 | 21.31 |
Best Pharma Penny Stocks Under Rs 100
The table below shows the Best Pharma Penny Stocks Under Rs 100 based on the highest day Volume.
| Name | Close Price (₹) | Daily Volume (Shares) |
| Morepen Laboratories Ltd | 83.34 | 7,034,487 |
| Syncom Formulations (India) Ltd | 20.49 | 2,789,859 |
| Medico Remedies Ltd | 57.95 | 2,519,879 |
| Murae Organisor Ltd | 1.4 | 1,180,434 |
| Vivanza Biosciences Ltd | 4.29 | 665,444 |
| Gennex Laboratories Ltd | 20.85 | 408,126 |
| Vivanta Industries Ltd | 3.77 | 337,569 |
| Ajooni Biotech Ltd | 7.88 | 289,723 |
| Remedium Lifecare Ltd | 6.72 | 282,209 |
| JFL Life Sciences Ltd | 28.15 | 252,000 |
List Of Best Pharma Penny Stocks Under Rs. 100
The table below shows a List Of The Best Pharma Penny Stocks Under Rs. 100 based on PE Ratio.
| Name | Close Price (₹) | PE Ratio |
| Ind Swift Ltd | 23.44 | 2.71 |
| Transchem Ltd | 43.9 | 8.67 |
| Chemo Pharma Laboratories Ltd | 86 | 9.81 |
| Desh Rakshak Aushdhalaya Ltd | 13.65 | 12.65 |
| Shukra Pharmaceuticals Ltd | 66.08 | 15.53 |
| Medico Intercontinental Ltd | 45.87 | 18.98 |
| Aarey Drugs and Pharmaceuticals Ltd | 64 | 25.99 |
| Emmessar Biotech and Nutrition Ltd | 52.74 | 27.15 |
| Colinz Laboratories Ltd | 63.27 | 28.41 |
| Ishita Drugs and Industries Ltd | 81.02 | 28.86 |
Who Should Invest In Pharma Penny Stocks Under Rs 100?
Investors who should consider pharma penny stocks under Rs 100 are those with high-risk tolerance, speculative investment strategies, and a thorough understanding of the pharmaceutical industry. Such investors must be prepared for significant volatility and the potential for both high returns and substantial losses.
How To Invest In The Pharma Penny Stocks Under Rs 100?
To invest in pharma penny stocks under Rs 100, research and select potential companies with promising pipelines or technologies. Use a reliable broker to buy shares, diversify your portfolio to mitigate risk, and stay updated on pharmaceutical industry news and regulatory changes affecting these stocks.
Performance Metrics Of Pharma Penny Stocks Under Rs 100
The performance metrics of pharma penny stocks under Rs 100 can be highly volatile, reflecting the speculative nature of these investments. Key indicators include share price fluctuations, trading volume, and financial health metrics such as earnings per share and revenue growth.
Investors should also consider the success rates of clinical trials, FDA approvals, and partnership developments as performance indicators. These metrics provide insights into a company’s potential to succeed in the competitive pharmaceutical market, impacting stock performance significantly.
Benefits Of Investing In Pharma Penny Stocks Under Rs 100
The main benefit of investing in pharma penny stocks under Rs 100 is the potential for high returns. These stocks often represent small companies that can experience significant growth if they achieve breakthroughs or gain regulatory approvals.
- High Return Potential: Pharma penny stocks can yield substantial profits if the company successfully brings a new drug to market or partners with larger pharmaceutical firms. Such events can dramatically increase a stock’s value overnight.
- Low Entry Cost: With shares priced under Rs 100, these stocks allow investors to buy a larger quantity of shares with a smaller initial investment, potentially maximizing gains if the stock value increases.
- Market Movements: These stocks are sensitive to market news and regulatory events, offering opportunities for quick gains from market reactions to positive news such as successful drug trials or government approvals.
- Diversification: Adding pharma penny stocks to a diversified investment portfolio can provide a balance to more stable investments. It introduces a higher-risk, higher-reward component that could yield returns uncorrelated with the broader market.
- Innovative Exposure: Investing in these stocks offers exposure to innovative medical research and potential breakthrough treatments that could revolutionize health care and generate significant financial returns if successful.
Challenges Of Investing In Pharma Penny Stocks Under Rs 100
The main challenges of investing in pharma penny stocks under Rs 100 include high volatility, limited liquidity, and significant regulatory risks. Additionally, these stocks often suffer from a lack of information and a higher potential for fraud, making them risky investments.
- High Volatility: Pharma penny stocks under Rs 100 are extremely volatile. Their prices can swing wildly based on news or market sentiment, making them unpredictable and increasing the risk of substantial losses for investors not prepared for such fluctuations.
- Limited Liquidity: These stocks often have lower trading volumes, which can make it difficult to buy or sell large quantities without affecting the stock price. This lack of liquidity can be a significant barrier when trying to exit positions at favorable prices.
- Regulatory Risks: The pharmaceutical industry is heavily regulated. Delays in drug approval processes or negative results from clinical trials can severely impact the stock’s value. Investors must be mindful of the regulatory environment and its potential effects.
- Lack of Information: Small pharmaceutical companies under Rs 100 often lack the visibility of larger companies. This scarcity of information can make it challenging for investors to perform thorough due diligence, assess the company’s potential, and make informed investment decisions.
- Fraud and Mismanagement Risk: The lower levels of scrutiny and oversight in smaller, less-regulated companies can lead to higher risks of fraud or mismanagement. Investors may face challenges in verifying the authenticity of the company’s claims and the integrity of its management.
Introduction To Pharma Penny Stocks Under Rs 100
Pharma Penny Stocks Under Rs 100 – Highest Market Capitalization
Morepen Laboratories Ltd
The Market Cap of Morepen Laboratories Ltd is ₹4,566.65 crore. The stock’s monthly return is 8.29%, while its one-year return is 131.18%. The stock is currently 134.43% away from its 52-week high.
Morepen Laboratories Ltd is a leading pharmaceutical company specializing in APIs, formulations, diagnostics, and over-the-counter (OTC) products. Established in 1984, the company serves global markets with a robust portfolio of health products and APIs. Its flagship brand, Dr. Morepen, has earned significant consumer trust.
Morepen focuses on innovation in the health sector with state-of-the-art facilities and cutting-edge research. The company’s global reach and strong market position make it a trusted name in the pharmaceutical and healthcare industries.
Syncom Formulations (India) Ltd
The Market Cap of Syncom Formulations (India) Ltd is ₹1,719.26 crore. The stock’s monthly return is 9.86%, and its one-year return is 125.16%. The stock is currently 126.41% away from its 52-week high.
Syncom Formulations (India) Ltd manufactures a wide range of pharmaceutical products, including tablets, capsules, liquids, and powders. With decades of expertise, the company caters to the domestic and export markets with affordable and quality formulations.
Committed to quality and innovation, Syncom Formulations is ISO-certified and operates with advanced facilities to meet global standards. It emphasizes customer-centric solutions and affordability, making it a significant player in the healthcare sector.
Nectar Lifesciences Ltd
The Market Cap of Nectar Lifesciences Ltd is ₹820.57 crore. The stock’s monthly return is -6.18%, while its one-year return is 49.35%. The stock is currently 53.74% away from its 52-week high.
Nectar Lifesciences Ltd is a fully integrated pharmaceutical company focusing on APIs and finished dosage forms. It operates in over 70 countries, offering high-quality, affordable medicines in critical therapeutic categories such as antibiotics and cardiovascular drugs.
With advanced manufacturing facilities and a strong emphasis on research, Nectar Lifesciences delivers exceptional value in healthcare. The company’s customer-centric approach ensures sustained growth and a significant presence in both domestic and global markets.
Top 10 Pharma Penny Stocks Under Rs 100 – 1 Year Return
Bacil Pharma Ltd
The Market Cap of Bacil Pharma Ltd is ₹28.88 crore. The stock’s monthly return is 51.15%, and its one-year return is 549.54%. The stock is currently 947.86% away from its 52-week high.
Bacil Pharma Ltd specializes in the manufacturing of APIs and intermediates used in critical drug formulations. The company provides its products to pharmaceutical clients worldwide, ensuring high-quality compliance and standards.
Through innovation and efficiency, Bacil Pharma has carved a niche for itself in the pharmaceutical industry. Its focus on API manufacturing and reliability makes it a preferred supplier for the global healthcare sector.
Gujarat Terce Laboratories Ltd
The Market Cap of Gujarat Terce Laboratories Ltd is ₹61.08 crore. The stock’s monthly return is 3.68%, and its one-year return is 243.24%. The stock is currently 262.76% away from its 52-week high.
Gujarat Terce Laboratories Ltd is a pharmaceutical company dedicated to manufacturing and marketing therapeutic and specialty drugs. Its product portfolio spans tablets, capsules, and injectables across multiple therapeutic areas.
With a strong focus on quality and innovation, the company meets the growing healthcare demands of the domestic market. Its commitment to R&D and customer satisfaction has propelled it to a competitive position in the pharmaceutical industry.
Shukra Pharmaceuticals Ltd
The Market Cap of Shukra Pharmaceuticals Ltd is ₹289.35 crore. The stock’s monthly return is 1.37%, and its one-year return is 164.80%. The stock is currently 210.42% away from its 52-week high.
Shukra Pharmaceuticals Ltd manufactures a wide array of pharmaceutical products, including tablets, syrups, and injectables. The company focuses on catering to domestic and international clients with high-quality and cost-effective solutions.
Shukra is dedicated to expanding its footprint through innovative product development and advanced manufacturing facilities. Its ability to adapt to market demands has earned it a respected position in the pharmaceutical industry.
Pharma Penny Stocks Under Rs 100 In India – 1 Month Return
Pharmaids Pharmaceuticals Ltd
The Market Cap of Pharmaids Pharmaceuticals Ltd is ₹266.52 crore. The stock’s monthly return is 75.56%, and its one-year return is 78.40%. The stock is currently 136.90% away from its 52-week high.
Pharmaids Pharmaceuticals Ltd manufactures APIs and finished pharmaceutical products for both the domestic and international markets. Its wide product portfolio focuses on affordability and accessibility to cater to a growing healthcare demand.
With an emphasis on R&D and quality, Pharmaids Pharmaceuticals ensures its products meet global standards. The company’s strategic vision is driving its growth across various healthcare segments.
Tiaan Consumer Ltd
The Market Cap of Tiaan Consumer Ltd is ₹6.48 crore. The stock’s monthly return is 46.59%, and its one-year return is 113.90%. The stock is currently 149.41% away from its 52-week high.
Tiaan Consumer Ltd focuses on health and wellness products, offering solutions across various consumer categories. Its innovative approach aligns with market trends to meet diverse consumer demands.
With a commitment to quality and affordability, Tiaan Consumer strives to make wellness accessible to all. The company’s growing product portfolio reflects its dedication to serving the evolving needs of the healthcare market.
Chemo Pharma Laboratories Ltd
The Market Cap of Chemo Pharma Laboratories Ltd is ₹12.90 crore. The stock’s monthly return is 44.63%, and its one-year return is 95.45%. The stock is currently 115.00% away from its 52-week high.
Chemo Pharma Laboratories Ltd produces a variety of pharmaceutical formulations for therapeutic and healthcare needs. The company has built a reputation for quality and customer satisfaction in the pharmaceutical industry.
Chemo Pharma focuses on operational efficiency and innovative practices to meet the demands of its clients. Its commitment to excellence drives its sustained growth and reliability.
Best Pharma Penny Stocks Under Rs 100 – Highest Day Volume
Medico Remedies Ltd
The Market Cap of Medico Remedies Ltd is ₹480.89 crore. The stock’s monthly return is 20.57%, and its one-year return is -24.15%. The stock is currently 66.52% away from its 52-week high.
Medico Remedies Ltd manufactures formulations and generics, serving both domestic and international markets. The company specializes in high-quality medicines, catering to therapeutic segments like cardiovascular and anti-infectives.
Medico Remedies is committed to expanding its market presence through innovation and partnerships. Its focus on delivering quality healthcare solutions aligns with its vision for long-term growth.
Murae Organisor Ltd
The Market Cap of Murae Organisor Ltd is ₹97.60 crore. The stock’s monthly return is 13.39%, and its one-year return is 26.13%. The stock is currently 42.86% away from its 52-week high.
Murae Organisor Ltd is engaged in providing healthcare-related products and services, with a focus on operational excellence. Its diversified offerings cater to evolving market demands across the pharmaceutical and healthcare sectors.
The company’s strategic approach and commitment to innovation make it a key player in the healthcare industry. It continues to drive growth with customer-centric solutions.
Vivanza Biosciences Ltd
The Market Cap of Vivanza Biosciences Ltd is ₹17.16 crore. The stock’s monthly return is 9.14%, while its one-year return is -63.95%. The stock is currently 27.68% away from its 52-week high.
Vivanza Biosciences Ltd develops innovative pharmaceutical and healthcare products for global markets. Its focus on R&D and quality manufacturing drives its growth and market relevance.
With a commitment to excellence, Vivanza Biosciences aims to meet the growing healthcare needs of the community through high-quality and affordable solutions. The company remains dedicated to sustainable growth.
List Of Best Pharma Penny Stocks Under Rs. 100 – PE Ratio
Ind Swift Ltd
The Market Cap of Ind Swift Ltd is ₹126.96 crore. The stock’s monthly return is 8.00%, and its one-year return is 41.63%. The stock is currently 63.92% away from its 52-week high.
Ind Swift Ltd is a pharmaceutical company specializing in APIs and formulations. With a strong focus on R&D and manufacturing, the company serves both domestic and global markets with high-quality products.
The company’s commitment to innovation and operational efficiency has strengthened its position in the healthcare sector. Ind Swift’s extensive product portfolio caters to various therapeutic areas, making it a trusted brand.
Transchem Ltd
The Market Cap of Transchem Ltd is ₹53.73 crore. The stock’s monthly return is 10.75%, and its one-year return is 63.38%. The stock is currently 75.53% away from its 52-week high.
Transchem Ltd specializes in chemical and pharmaceutical products, serving diverse industrial and healthcare needs. The company has built a strong reputation for delivering reliable and quality products.
With a strategic focus on operational efficiency and client satisfaction, Transchem is expanding its reach in the global market. Its dedication to quality ensures long-term success.
Desh Rakshak Aushdhalaya Ltd
The Market Cap of Desh Rakshak Aushdhalaya Ltd is ₹6.06 crore. The stock’s monthly return is 10.17%, and its one-year return is 127.12%. The stock is currently 127.12% away from its 52-week high.
Desh Rakshak Aushdhalaya Ltd produces ayurvedic and herbal formulations, catering to both traditional and modern healthcare needs. The company’s focus on natural remedies aligns with the increasing demand for holistic healthcare solutions.
Through innovation and research, Desh Rakshak is expanding its product portfolio and market presence. Its dedication to sustainability and quality enhances its reputation in the healthcare industry.
Top 10 Pharma Penny Stocks Under Rs 100- FAQs
Best Pharma Penny Stocks Under Rs 100 # 1: Morepen Laboratories Ltd
Best Pharma Penny Stocks Under Rs 100 # 2: Syncom Formulations (India) Ltd
Best Pharma Penny Stocks Under Rs 100 # 3: Nectar Lifesciences Ltd
Best Pharma Penny Stocks Under Rs 100 # 4: Medico Remedies Ltd
Best Pharma Penny Stocks Under Rs 100 # 5: Gennex Laboratories Ltd
The Best Pharma Penny Stocks Under Rs 100 are based on market capitalization.
Based on the one-year return, Bacil Pharma Ltd, Gujarat Terce Laboratories Ltd, Shukra Pharmaceuticals Ltd, Morepen Laboratories Ltd, and Desh Rakshak Aushdhalaya Ltd.
Yes, you can invest in pharma penny stocks under Rs 100, but it involves high risk. Thorough research and a clear understanding of the risks associated with such speculative investments are essential.
Investing in pharma penny stocks under Rs 100 can be profitable but is highly risky. It suits investors who are comfortable with potential high volatility and the possibility of significant financial losses.
To invest in pharma penny stocks under Rs 100, research thoroughly, choose a reputable brokerage, monitor the pharmaceutical industry closely, and diversify your investments to mitigate risks.
Here are some of the Best Stock Research Articles listed based on Top Sectors (Industries), Market Cap, and Fundamental Analysis Factors:
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.
